By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Neon Therapeutics 

215 First Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-337-4701 Fax: n/a


NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.




Founders: James Allison, Ed Fritsch, Nir Hacohen, and Eric Lander

CEO: Hugh O'Dowd

CBO: Robert Ang

CTO: ED Fritsch

CMO: Barbara Weber

CFO: Daniella Beckman


Please click here for Neon job opportunities.

Key Statistics

Ownership: Private

Web Site: Neon Therapeutics


Company News
Neon Therapeutics Release: Using Mono-Allelic Mass Spectrometry Data To Improve Epitope Prediction Algorithms Published In Immunity 2/21/2017 8:32:28 AM
Massachusetts Startup Neon Therapeutics Rakes in $70 Million for Personalized Cancer Vaccines 1/5/2017 5:42:34 AM
The Next Generation: Top 20 Life Science Startups to Watch in 2017 1/3/2017 3:19:44 PM
What You Need to Know About Neon Therapeutics 1/3/2017 2:56:22 PM
Neon Therapeutics Announces First Patient Enrolled In Inaugural Clinical Trial For Personalized Cancer Vaccine NEO-PV-01 11/17/2016 8:53:39 AM
Neon Therapeutics Appoints Dr. Richard Gaynor To President Of Research And Development 11/7/2016 10:29:57 AM
Neon Therapeutics Taps Former Novartis AG (NVS) Cancer Vet as New CEO 9/27/2016 6:13:38 AM
Neon Therapeutics Announces FDA Acceptance Of Investigational New Drug Application For Cancer Vaccine NEO-PV-01 7/29/2016 10:16:22 AM
Neon Therapeutics Enters Collaborative Research Agreement With The Netherlands Cancer Institute (NCI) 2/23/2016 8:24:53 AM
Neon Therapeutics Enters License Agreement With Sanquin Blood Supply Foundation For Peptide-MHC Assay Technology 2/17/2016 10:41:03 AM